Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin vs Alprazolam vs Placebo for Dental Anxiety
2005-003006-29Phase 2Completed
- Sponsor
- Pfizer
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in anxiety disorder comparing Pregabalin (Lyrica), Alprazolam IR (Xanax) and Placebo (3 arms). Primary endpoints: Change in anxiety symptoms at 4 hours post-dose and Onset and time course of anxiety reduction. Started Aug 2005; status: completed.
02
Drugs
pregabalinalprazolam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on 2005-003006-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003006-29.